I65L (p.Ile65Leu) variant of HTR2C (5-hydroxytryptamine receptor 2C)
I65L (p.Ile65Leu) in HTR2C (5-hydroxytryptamine receptor 2C) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and structural context.
I65L (p.Ile65Leu) variant details
- p.Ile65Leu
- NCI-TCGA Cosmic COSV5220
- cosmic curated COSV52209
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.03
- MetaSVM -0.98
- SIFT 0.17
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available